HPV-16 E7 vaccine (Loyola University of Chicago)

N/A

Report date: 2023/06/26 09:15:30

Base Information

Drug NameHPV-16 E7 vaccine (Loyola University of Chicago)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLoyola University Chicago
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLoyola University Chicago
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A